Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$15,829,467
New position
Shares Held
80,263
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 78.93727029215722.ToString("F0")%
Shared 0.ToString("F0")%
None 21.06272970784277.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $221,310,249 across 15 Drug Manufacturers - General names. AZN ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
226,615 | $55,393,769 | |
| 2 | LLY |
ELI LILLY & Co
|
51,627 | $47,484,964 | |
| 3 | ABBV |
AbbVie Inc.
|
138,202 | $30,057,552 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
80,263 | $15,829,467 | |
| 5 | MRK |
Merck & Co., Inc.
|
124,118 | $14,930,153 | |
| 6 | PFE |
Pfizer Inc
|
446,491 | $12,537,466 | |
| 7 | AMGN |
Amgen Inc
|
27,190 | $9,566,800 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
68,638 | $9,566,077 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,829,467 | 80,263 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||